Healthcare - Biotechnology - NASDAQ - US
$ 1.04
0.971 %
$ 57.2 M
Market Cap
-0.59
P/E
Price Target
Average
380.77%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
11.11%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Prelude Therapeutics Incorporated
Wall Street analysts predict an average 1-year price target for PRLD of $5 , with forecasts ranging from a low of $3 to a high of $7 .
PRLD Lowest Price Target
Wall Street Target
3 USD
188.46%
PRLD Average Price Target
Wall Street Target
5 USD
380.77%
PRLD Highest Price Target
Wall Street Target
7 USD
573.08%
REVENUE FORECAST
Revenue Forecast Chart PRLD
EBIT FORECAST
EBIT Forecast Chart PRLD
NET INCOME FORECAST
Net Income Chart PRLD